Letters to the Editor

Real-world analysis of thromboprophylaxis use during autologous hematopoietic stem cell transplantation for multiple myeloma

Division of Hematology and Cellular Therapy, Department of Medicine, Cedars Sinai Medical Center, Los Angeles, CA 90048
Division of Hematology and Cellular Therapy, Department of Medicine, Cedars Sinai Medical Center, Los Angeles, CA 90048
Division of Hematology and Cellular Therapy, Department of Medicine, Cedars Sinai Medical Center, Los Angeles, CA 90048
Department of Pharmacy, Cedars Sinai Medical Center, Los Angeles, CA 90048
Department of Pharmacy, Cedars Sinai Medical Center, Los Angeles, CA 90048
Division of Hematology and Cellular Therapy, Department of Medicine, Cedars Sinai Medical Center, Los Angeles, CA 90048
Division of Hematology and Cellular Therapy, Department of Medicine, Cedars Sinai Medical Center, Los Angeles, CA 90048
Division of Hematology and Cellular Therapy, Department of Medicine, Cedars Sinai Medical Center, Los Angeles, CA 90048
Division of Hematology and Cellular Therapy, Department of Medicine, Cedars Sinai Medical Center, Los Angeles, CA 90048
Division of Hematology and Cellular Therapy, Department of Medicine, Cedars Sinai Medical Center, Los Angeles, CA 90048
Department of Pharmacy, City of Hope, Duarte, CA 91010
Division of Hematology and Cellular Therapy, Department of Medicine, Cedars Sinai Medical Center, Los Angeles, CA 90048
Division of Hematology and Cellular Therapy, Department of Medicine, Cedars Sinai Medical Center, Los Angeles, CA 90048; Regenerative Medicine Institute, Cedars Sinai Medical Center, Los Angeles, CA 90048; Samuel Oschin Cancer Center, Cedars Sinai Medical Center, Los Angeles, CA 90048
Department of Pathology, Cedars Sinai Medical Center, Los Angeles, CA 90048
Division of Hematology and Cellular Therapy, Department of Medicine, Cedars Sinai Medical Center, Los Angeles, CA 90048
Haematologica Early view Oct 29, 2026 https://doi.org/10.3324/haematol.2026.301181